Neurology · 2020 · 60 citations · 35 references
Life SciencesNeurologyNeuroscienceClinical NeuroscienceNeurodegenerationNeuropsychiatryBiomarkers Of NeurodegenerationCerebrospinal Fluid BiomarkersCognitive ImpairmentNeurodegenerative DiseasesNeurodegenerative DisordersBrain Function MappingNeurologic DeficitsNeuropsychiatric EffectsNeuropsychiatric ManifestationsNeuropsychological FunctioningPhenylalanine MetabolismSensory AbnormalitiesTotal Tau Protein
<h3>Objective</h3> To evaluate the relationship between circulating phenylalanine and brain function as well as neuropsychiatric symptoms in adults with phenylketonuria. <h3>Methods</h3> In this prospective cross-sectional study, early-treated patients with phenylketonuria older than 30 years and age- and sex-matched controls were included. Extensive neurologic evaluation, neuropsychological and behavioral testing, sensory and motor evoked potentials, and MRI were performed. CSF concentrations of neurodegenerative markers were evaluated in addition in a subset of 10 patients. <h3>Results</h3> Nineteen patients with phenylketonuria (median age 41 years) with different phenylalanine levels (median 873 μmol/L) entered the study. They showed higher prevalence of neurologic symptoms, cognitive and behavioral abnormalities, autonomic dysfunction, alterations in neurophysiologic measures, and atrophy in putamen and right thalamus compared to controls. In CSF, patients with phenylketonuria exhibited higher β-amyloid 1-42 (<i>p</i> = 0.003), total tau (<i>p</i> < 0.001), and phosphorylated tau (<i>p</i> = 0.032) levels compared to controls. Plasma phenylalanine levels highly correlated with the number of failed neuropsychological tests (<i>r</i> = 0.64, <i>p</i> = 0.003), neuropsychiatric symptoms (<i>r</i> = 0.73, <i>p</i> < 001), motor evoked potential latency (<i>r</i> = 0.48, <i>p</i> = 0.030), and parietal lobe atrophy. <h3>Conclusions</h3> Our study provides strong evidence for a correlation between phenylalanine levels and clinical, neuropsychological, neurophysiologic, biochemical, and imaging alterations in adult patients with phenylketonuria.
35
Phenylalanine hydroxylase deficiency: diagnosis and management guideline
Jerry Vockley, Hans C. Andersson, Kevin M. Antshel et al. · Genetics in Medicine · 2014 · 722 citations · Full text
Evolution of prodromal Parkinson’s disease and dementia with Lewy bodies: a prospective study
Seyed‐Mohammad Fereshtehnejad, Chun Yao, Amélie Pelletier et al. · Brain · 2019 · 378 citations · Full text
Medicine, Neurology, Neuroscience +17
Computing average shaped tissue probability templates
John Ashburner, Karl Friston · NeuroImage · 2008 · 240 citations